81. Formation of non-ferromagnetic grain boundary phase in a Ga-doped Nd-rich Nd–Fe–B sintered magnet. (1st March 2016) Authors: Sasaki, T.T.; Ohkubo, T.; Takada, Y.; Sato, T.; Kato, A.; Kaneko, Y.; Hono, K. Journal: Scripta materialia Issue: Volume 113(2016) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
82. Formation of non-ferromagnetic grain boundary phase in a Ga-doped Nd-rich Nd–Fe–B sintered magnet. (1st March 2016) Authors: Sasaki, T.T.; Ohkubo, T.; Takada, Y.; Sato, T.; Kato, A.; Kaneko, Y.; Hono, K. Journal: Scripta materialia Issue: Volume 113(2016) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
83. FRI0010 Comparison with Radiographic Joint Damage in Patients with Rheumatoid Arthritis with the Continuation or Discontinuation of RAPID3 Remission during 1 Year. (10th June 2014) Authors: Katayama, K.; Okubo, T.; Sato, T.; Kamiya, K.; Fukai, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
84. FRI0067 Prognostic factors for rapid radiographic progression are different between tnf and non-tnf inhibitor. (23rd January 2014) Authors: Katayama, K.; Sato, T.; Okubo, T.; Fukai, R.; Ito, H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
85. FRI0124 Prevention of extensive bone marrow oedema and consequent rapid radiographic progression by short term usage of biologics in drards resistant patients with early destructive rheumatoid arthritis. (12th June 2018) Authors: Katayama, K.; Okubo, T.; Sato, T.; Fukai, R.; Kon, Y.; Makino, Y.; Kodama, S.; Ito, H. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
86. FRI0127 Suppression of radiographic progression after gradual methotrexate tapering in patients with rheumatoid arthritis patients maintaining low disease activity - Prospective multicenter study-. (2nd June 2020) Authors: Katayama, K.; Yujiro, K.; Okubo, T.; Fukai, R.; Sato, T.; Yuichi, M.; Abe, S.; Ito, H. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
87. FRI0237 Study of the antibody titer by influenza vaccination in rheumatoid arthritis patients treated with biological agents. (23rd January 2014) Authors: Ishikawa, H.; Kanda, H.; Kida, D.; Kaneko, A.; Katayama, M.; Sato, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
88. FRI0253 Increase of medium and large joint destruction in patients with rapid radiographic progression during treatment with tocilizumab. (23rd January 2014) Authors: Katayama, K.; Sato, T.; Okubo, T.; Fukai, R.; Ito, H.; Kamishima, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
89. FRI0286 Clinical Significance of Serum Matrix Metalloproteinase-3 Normalisation in Rheumatoid Arthritis Patients with Anti-TNF Therapy. (10th June 2014) Authors: Hattori, Y.; Kaneko, A.; Kida, D.; Takahashi, N.; Ishikawa, H.; Kanda, H.; Sato, T.; Kojima, T.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
90. FRI0287 High Rate of Improvement in Serum Matrix Metalloproteinase-3 Levels at 4 Weeks PREDICT Remission at 52 Weeks in RA Patients with Anti-TNF Therapy. (10th June 2014) Authors: Hattori, Y.; Kaneko, A.; Kida, D.; Takahashi, N.; Ishikawa, H.; Kanda, H.; Sato, T.; Kojima, T.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗